ISSN: 2155-9570
Anand Sudhalkar
India
Research Article
Outcomes of Post-Operative Topical Bevacizumab in Primary Pterygium Surgery: A Case Series
Author(s): Aditya Sudhalkar and Anand SudhalkarAditya Sudhalkar and Anand Sudhalkar
Background: To determine the efficacy and tolerability of topical bevacizumab as an postoperative adjunct in reduction of recurrence following primary pterygium surgery with conjunctival graft at a two year follow up.
Methods: Prospective, non randomized case series. Twenty three consecutive patients with primary pterygium, without any ocular or systemic contraindication to bevacizumab were recruited for the study, with informed consent. All patients underwent primary pterygium excision with rotational conjunctival autograft. Postoperative regimen included plain antibiotic eye drops, preservative-free artificial tears from post operative day 1 and topical bevacizumab (1.25 mg/day), from day 4 postoperatively, q.i.d, for 30 days. Primary outcome measure: Recurrence of pterygium and side effects of treatment.
Results: Mean.. View More»